Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Changes in the MRI Signal in Patients With Benign Tumors of the Brain and Meninges Treated With Proton Therapy: Impact of TEL and the Biological Dose Received

NCT04584086 is registered in ClinicalTrials.gov with Centre Francois Baclesse as lead sponsor.

NCT NCT04584086
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04584086 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Changes in the MRI Signal in Patients With Benign Tumors of the Brain and Meninges Treated With Proton Therapy: Impact of TEL and the Biological Dose Received
Lead sponsor
Centre Francois Baclesse
Phase
Not applicable
Overall status
Completed
Start date
April 22, 2021
Completion date
February 27, 2023
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

benign brain tumors, proton therapy